Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News

YouTube

SEARCH NEWS

Format: 04/16/2014
Format: 04/16/2014

News

Pittsburgh Business Times: Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment

Monday, February 15th, 2010

PITTSBURGH, Feb. 12 /PRNewswire-USNewswire/ -- An oral allergy treatment administered in drops under the tongue is a safe and effective alternative to injections for adults who are allergic to ragweed pollen, according to a study published today in the Journal of Allergy and Clinical Immunology by allergic disease specialist at Allegheny General Hospital.

Widely used in Europe, but not yet approved by the U.S. Food and Drug Administration, sublingual allergen immunotherapy (SLIT) can be a more convenient and tolerable treatment approach that leads to greater patient compliance, said David Skoner, MD, director of AGH's Division of Allergy, Asthma and Immunology and a co-lead investigator in the study.

"The study's findings mark a step forward in gaining approval for sublingual administration of allergy medication," said Dr. Skoner, "We believe a large number of patients would greatly benefit from having access to this new oral treatment to ease their symptoms."

"The sublingual method so far has been safe, and the adherence rate should be better because no injections are involved and the medication is administered at home," said co-investigatorDeborah Gentile, MD, Director of Research in AGH's Division of Allergy, Asthma and Immunology.

For more information, visit the Pittsburgh Business Times website.

 

X
West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)











Did you find what you were looking for?


Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 7 + 6 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.